Stock Movers: BNP Paribas, HSBC, Novartis (Podcast)
Source: Bloomberg, 4:25 www.bloomberg.com #Stock #Movers #BNP #Paribas #HSBC #Novartis #Podcast
Tag: Novartis
Swiss drugmaker Novartis to buy Avidity Biosciences for $12 billion
Swiss drugmaker Novartis on Sunday said it agreed to acquire U.S. biotech firm Avidity Biosciences for about $12 billion in…
Novartis to acquire Avidity Biosciences for about $12 billion
By Padmanabhan Ananthan and Angela Christy M (Reuters) -Swiss drugmaker Novartis on Sunday said it agreed to acquire U.S. biotech…
Novartis Agrees to Buy Avidity Biosciences in $12 Billion Deal
Novartis AG agreed to buy biotechnology company Avidity Biosciences Inc. in a deal that values it at $12 billion, according…
Novartis Avidity Biosciences in talks
Signage for Novartis AG at a building in the company’s headquarters campus in Basel, Switzerland, on Monday, Jan. 8, 2023. …
Novartis Said to Near $70-Per-Share-Plus Deal for Avidity
Novartis AG is nearing a deal to buy biotechnology company Avidity Biosciences Inc., according to a person familiar with the…
In Novartis patent case, India has a BIT of cover
The Indian Patent Office (IPO) has revoked the patent of Novartis for its blockbuster cardiac drug, Vymada, based on a…
Novartis has stockpiles to withstand potential Trump tariffs, CEO says
ZURICH (Reuters) — Novartis (NVS) has increased its stockpiles of pharmaceuticals in the United States and is well prepared should…
Novartis to buy U.S. biotech in latest deal targeting firms in $1 billion to $3 billion range
Novartis on Tuesday said it was buying a U.S. biotech working on a cardiovascular drug, continuing what’s been a flurry…
Novartis Agrees to Buy Tourmaline Bio for $48 Per Share in Cash
Novartis AG said it agreed to acquire Tourmaline Bio, Inc. at an offer price of $48 per share in cash,…